Rabbit Polyclonal APPBP2 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human APPBP2 aa 300 to C-terminus.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 20% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
IHC-P | WB | ICC/IF | |
---|---|---|---|
Human | Tested | Tested | Tested |
Mouse | Predicted | Predicted | Predicted |
Rat | Predicted | Predicted | Predicted |
Chicken | Predicted | Predicted | Predicted |
Zebrafish | Predicted | Predicted | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100.00000 - 1/1000.00000 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Chicken, Zebrafish | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/500.00000 - 1/3000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Chicken, Zebrafish | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/100.00000 - 1/1000.00000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat, Chicken, Zebrafish | Dilution info - | Notes - |
Substrate-recognition component of a Cul2-RING (CRL2) E3 ubiquitin-protein ligase complex of the DesCEND (destruction via C-end degrons) pathway, which recognizes a C-degron located at the extreme C terminus of target proteins, leading to their ubiquitination and degradation (PubMed:29775578, PubMed:29779948). The C-degron recognized by the DesCEND pathway is usually a motif of less than ten residues and can be present in full-length proteins, truncated proteins or proteolytically cleaved forms (PubMed:29775578, PubMed:29779948). The CRL2(APPBP2) complex specifically recognizes proteins with a -Arg-Xaa-Xaa-Gly degron at the C-terminus, leading to their ubiquitination and degradation (PubMed:29775578, PubMed:29779948). The CRL2(APPBP2) complex mediates ubiquitination and degradation of truncated SELENOV selenoproteins produced by failed UGA/Sec decoding, which end with a -Arg-Xaa-Xaa-Gly degron (PubMed:26138980). May play a role in intracellular protein transport: may be involved in the translocation of APP along microtubules toward the cell surface (PubMed:9843960).
KIAA0228, PAT1, APPBP2, Amyloid protein-binding protein 2, Amyloid beta precursor protein-binding protein 2, Protein interacting with APP tail 1, APP-BP2
Rabbit Polyclonal APPBP2 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 2 publications. Immunogen corresponding to Recombinant Fragment Protein within Human APPBP2 aa 300 to C-terminus.
pH: 7
Preservative: 0.01% Thimerosal (merthiolate)
Constituents: 20% Glycerol (glycerin, glycerine), 1.21% Tris, 0.75% Glycine
APPBP2 is also known as amyloid precursor protein-binding protein 2 or PAT1. This protein has a molecular weight of roughly 135 kDa. APPBP2 acts as an adaptor molecule and plays a mechanical role in intracellular transport processes. It interacts directly with microtubule-associated proteins facilitating vesicular transport along the cytoskeletal network. APPBP2 expression is found prominently in the brain and lymphocytes hinting at its significance in these areas.
APPBP2 contributes to cellular processes by involving itself in the regulation of protein transport. It is part of a larger protein complex which includes kinesins that mediates cargo movement within cells. This action influences various cellular functions including cell signaling and neurotransmitter release. Through its interactions APPBP2 can affect synaptic activity by modulating the trafficking of synaptic vesicles and other cargo pertinent to neuronal communication.
APPBP2 engages with the Wnt signaling pathway and neuronal apoptosis pathway. APPBP2 demonstrates a regulatory role by interacting with proteins such as beta-catenin in the Wnt pathway. These interactions influence gene expression and cell proliferation. In neuronal apoptosis APPBP2 acts in coordination with amyloid precursor protein (APP) further dictating cell survival and neurodegeneration processes.
APPBP2 has implications in Alzheimer's disease and lymphomas. In Alzheimer's disease APPBP2 affects the processing of amyloid precursor protein connecting it to the pathogenesis of amyloid plaques characteristic of this condition. In lymphomas altered expression levels of APPBP2 may interact with oncogenic proteins contributing to tumor progression. This involvement links APPBP2 to broader cellular pathways and emphasizes its role in pathological contexts.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
7.5% SDS PAGE
All lanes: Western blot - Anti-APPBP2 antibody (ab151305) at 1/1000 dilution
All lanes: Jurkat whole cell lysate at 30 µg
Predicted band size: 67 kDa
Immunohistochemical analysis of paraffin-embedded Ca922 xenograft tissue labeling APPBP2 with ab151305 antibody at 1/100 dilution.
Immunofluorescent analysis of methanol-fixed HeLa cells labeling APPBP2 with ab151305 antibody at 1/100 dilution. Bottom figure represents cells costained with Hoechst 33342.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com